Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Asset disposition Inv. presentation Quarterly results
|
IDEAYA Biosciences, Inc. (IDYA)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
03/24/2023 |
SC 13G
| BIOTECHNOLOGY VALUE FUND L P reports a 5.1% stake in IDEAYA Biosciences, Inc. |
02/27/2023 |
SC 13G
| ADAGE CAPITAL PARTNERS GP, L.L.C. reports a 5.4% stake in IDEAYA Biosciences, Inc. |
10/27/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
05/02/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
03/18/2022 |
SC 13G
| Logos Global Management LP reports a 6.9% stake in IDEAYA Biosciences, Inc. |
02/18/2022 |
SC 13G
| Point72 Asset Management, L.P. reports a 5.3% stake in IDEAYA Biosciences, Inc. |
02/14/2022 |
SC 13G
| PRICE T ROWE ASSOCIATES INC reports a 7% stake in IDEAYA Biosciences, Inc. |
02/14/2022 |
SC 13G
| FEDERATED HERMES, INC. reports a 6% stake in IDEAYA BIOSCIENCES, INC. |
02/04/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
12/01/2021 |
SC 13G
| Avidity Partners Management LP reports a 6.4% stake in IDEAYA Biosciences, Inc. |
01/22/2021 |
SC 13G
| RTW INVESTMENTS, LP reports a 7.2% stake in IDEAYA Biosciences, Inc. |
06/29/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
04/23/2020 |
SC 13G
| WuXi Healthcare Ventures II, L.P. reports a 6.9% stake in IDEAYA Biosciences, Inc. |
02/13/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
02/06/2020 |
SC 13G
| CANAAN X L.P. reports a 13.1% stake in IDEAYA Biosciences, Inc. |
06/07/2019 |
SC 13G
| BIOTECHNOLOGY VALUE FUND L P reports a 7.4% stake in IDEAYA Bioscience, Inc. |
05/30/2019 |
SC 13G
| CELGENE CORP reports a 8.4% stake in IDEAYA Biosciences, Inc. |
05/29/2019 |
SC 13G
| PERCEPTIVE ADVISORS LLC reports a 6.9% stake in IDEAYA Biosciences, Inc. |
|
|